Mar 22, 2025, 06:29 | Blog

Tania Fleitas Kanonnikoff: Understanding of tumor-immune interactions and identify subgroups benefiting from immunotherapy

Tania Fleitas Kanonnikoff, Medical Oncologist at Incliva Biomedical Research Institute, posted on X about recent…

Mar 20, 2025, 09:17 | Oncolibrary

FDA approval: Pembrolizumab for HER2 positive gastric or GEJ adenocarcinoma expressing PD-L1 (CPS ≥1): KEYNOTE-811 Trial

FDA granted traditional approval on march 19, 2025 for pembrolizumab (Keytruda, Merck) in combination with…

Mar 12, 2025, 06:22 | Blog

Advanced Gastric Cancer 2025 ESMO Webinar on ESMO On Air

ESMO - European Society for Medical Oncology shared a post on LinkedIn: "Gain valuable knowledge…

Mar 9, 2025, 04:38 | Blog

Sakditad Saowapa: Excited to present my first oral abstract at the JSMO25 conference

Sakditad Saowapa, Oncologist at UI Holden Comprehensive Cancer Center, shared a post on X: "Excited…

Mar 8, 2025, 22:46 | Science

Florian Lordick: Important gastric cancer publication from LEGACY consortium connecting Latin America and Europe

Florian Lordick, Professor of Medicine at the University of Leipzig, shared a post on LinkedIn…

Mar 7, 2025, 15:39 | Insight

MATTERHORN trial - FLOT plus durvalumab will become the new standard of care in the preoperative setting for gastroesophageal cancer

Today, AstraZeneca announced positive results from the MATTERHORN study where the chemotherapy regimen FLOT (fluorouracil,…

Mar 5, 2025, 12:01 | Blog

A Novel Approach to Attacking Gastric Cancer - Sylvester Comprehensive Cancer Center

Sylvester Comprehensive Cancer Center shared a post on LinkedIn: "A $100,000 Grant is Helping Sylvester Researchers…

Mar 4, 2025, 11:18 | Blog

Elvina Almuradova: ENHERTU Brings New Hope for Gastric Cancer

Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared a…

Mar 4, 2025, 08:14 | Blog

Kohei Shitara: DESTINY-Gastric04 demonstrated significantly prolonged OS in gastric cancer

Kohei Shitara, Medical Oncologist at National Cancer Center Hospital East, Japan, shared a post on…

Feb 26, 2025, 15:12 | Blog

The powerful synergy between MiNK’s allo-iNKT cells and chemotherapy in Gastric Cancer - MiNK Therapeutics

MiNK Therapeutics shared a post on LinkedIn: "Yesterday at AACRIO25, we presented new translational insights…

Feb 26, 2025, 10:59 | Science

Elvina Almuradova: How GEMSTONE-303 differs from other trials

Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared an…

Feb 5, 2025, 13:42 | Oncolibrary

NEW PAPER ALERT: ESOPEC trial on Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer

The phase 3 ESOPEC trial compared perioperative FLOT vs. chemoradiotherapy in gastric cancer, revealing improved…

Feb 4, 2025, 22:36 | Blog

Nina Niu Sanford: An overview of GI radiation oncology

Nina Niu Sanford, Assistant Professor and Chief of Gastrointestinal Radiation Oncology at Harvard/Brigham and Women’s…

Feb 3, 2025, 05:44 | Blog

Rawia Mohamed: Data on MMR and MSI testing in paired biopsy and surgical specimens from resectable GC/GEJC

Rawia Mohamed, Head of the Anatomical Pathology Department at Burjeel Medical City and an Associate…

Jan 27, 2025, 08:07 | Blog

Smitha Krishnamurthi: Masterclass on treatment of gastric cancer carcinomatosis by Maheswari Senthil

Smitha Krishnamurthi, Gastrointestinal medical oncologist at Cleveland Clinic, shared a post on X: "Masterclass on…

Jan 26, 2025, 15:37 | Blog

Nicholas Hornstein: HER2 blockade in resectable gastric cancer without benefit

Nicholas Hornstein, Assistant Professor of Medical Oncology at Northwell Health, shared a post on X:…

Jan 26, 2025, 14:23 | Blog

Marcia Cruz-Correa: Gastric Cancer 1st line therapy biomarkers at ASCO GI 2025

Marcia Cruz-Correa, Chief Medical Officer at PanOncology Trials, shared a post on X: "Participating in…

Jan 24, 2025, 14:12 | Blog

Despina Siolas: Are you confused about biomarker testing in gastric cancer?

Despina Siolas, Assistant Professor at Weill Cornell Medicine, posted on X: "Are you confused about…

Jan 24, 2025, 13:55 | Blog

Udhayvir Grewal: Excellent discussion on TNT in gastric cancer

Udhayvir Grewal, Resident Physician at Ochsner LSU Health Shreveport Academy Medical Centre, posted on X:…

Jan 24, 2025, 13:02 | Drugs

Pashtoon Kasi: Impact of HER2 blockade with trastuzumab in addition to chemotherapy in resectable gastric cancer

Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope, shared a post…

Jan 24, 2025, 04:18 | Blog

Toufic Kachaamy: Call for Papers on Gastrointestinal Oncology

Toufic Kachaamy, Chief of Medicine and Medical Director of Gastroenterology at City of Hope, Phoenix,…

Jan 23, 2025, 14:32 | Blog

Amol Akhade: Intraperitoneal chemotherapy may hold promise for gastric cancer

Amol Akhade, Consultant Medical Oncologist and Hemato-oncologist at Suyog Cancer Clinics, shared the following on X:…

Jan 15, 2025, 06:40 | Blog

Elevation Oncology Advances Clinical Trials for Gastric Cancer: Data Updates for 2025

Elevation Oncology has announced updates on its ongoing clinical trials and forthcoming milestones for its…

Dec 28, 2024, 13:43 | Insight

TEVIMBRA Received FDA Approval as First-Line Therapy for Gastric and GEJ Cancers in Combination with Chemotherapy

The additional indication for first-line treatment of gastric and gastroesophageal junction cancers is supported by…

Dec 28, 2024, 11:40 | Science

Elvina Almuradova: Tislelizumab-jsgr with chemotherapy as a first-line treatment for metastatic HER2-negative GEJ adenocarcinoma

Elvina Almuradova, Associate Professor at Medicana Health Group, posted on LinkedIn: "The FDA has approved…

Dec 28, 2024, 11:14 | Science

Amol Akhade: Tislelizumab gets FDA approval for Metastatic GE junction adenocarcinoma based upon rationale 305 trial

Amol Akhade, Hemato-oncologist at Suyog Cancer Clinics and Reliance Hospitals, posted on X: "Tislelizumab gets…

Dec 25, 2024, 16:51 | Science

Akhil Santhosh: Perioperative doublet vs triplet study for locally advanced gastric cancer

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared a post…

Dec 24, 2024, 12:09 | Blog

Personalized Cancer Therapy: The Role of Individualized Neoantigen Therapy

Dundee Patient Becomes the First in Europe to Receive mRNA-Based Cancer Therapy, personalized cancer treatment…

Dec 21, 2024, 13:05 | Cancer Types

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis and Treatment

Esophageal cancer is a malignant condition arising from the lining of the esophagus, the muscular…

Dec 8, 2024, 13:07 | Insight

Filippo Pietrantonio: Tremelimumab and durvalumab for MSI gastric cancer

Filippo Pietrantonio, GI medical oncologist at the National Cancer Institute of Milan, shared a recent…

Dec 3, 2024, 09:23 | Blog

Adding preoperative chemoradiotherapy for gastric cancer shows no survival benefit - EORTC

EORTC - European Organisation for Research and Treatment of Cancer posted the following on LinkedIn:…

Nov 30, 2024, 12:12 | Insight

United in November: Raising Awareness and Taking Action in the Fight Against Disease

November is an important month in medicine. During this month, healthcare professionals, organizations, and individuals…

Nov 29, 2024, 15:48 | Blog

Namrata Vijayvergia: Precision Medicine is changing the face of systemic therapy for Gastric Cancer

Namrata Vijayvergia, GI Medical Oncologist at the Fox Chase Cancer Center, shared a post by Fox Chase…

Nov 25, 2024, 15:59 | Blog

Gastric Cancer Awareness Month 2024

November is Gastric Cancer Awareness Month, a time to raise awareness about gastric (stomach) cancer.…

Nov 24, 2024, 00:46 | Insight

November 2024 Tip Sheet of Sylvester Comprehensive Cancer Center

This month’s tip sheet from Sylvester Comprehensive Cancer Center at the University of Miami Miller…

Nov 20, 2024, 16:29 | Blog

Researchers Seek to Understand and Address Stomach Cancer Disparities - Sylvester Comprehensive Cancer Center

Stomach cancer, also known as gastric cancer, is relatively rare in the United States, constituting…

Nov 19, 2024, 20:55 | Blog

Rawia Mohamed: Updates and Insights on MMR in Colorectal Cancer

Rawia Mohamed, Head of the Anatomical Pathology Department at Burjeel Medical City, shared a post…

Nov 16, 2024, 15:52 | Insight

Lucjan Wyrwicz: Immunotherapy in cancer is a story of success

Lucjan Wyrwicz, Head of Department, Dept. of Oncology and Radiotherapy at Maria Skłodowska-Curie Memorial Cancer…

Nov 12, 2024, 13:21 | Insight

Perioperative XELOX for gastric cancer with extensive lymph node metastases

Erman Akkus, Medical oncology fellow at the Ankara University, shared an article by Yutaka Kimura…

Nov 11, 2024, 03:14 | Insight

Raghav Sundar: Understanding Resistance Mechanisms in HER2+ Gastric Cancer

Raghav Sundar, Leader Gastroesophageal Cancer Program, Associate Professor of Medicine (Oncology), Yale University School of…

Nov 8, 2024, 15:40 | Blog

DDF Hosts Gastric Cancer Awareness Illumination Ceremony and Celebration Dinner on November 9th

Debbie's Dream Foundation: Curing Stomach Cancer (DDF) aims to raise awareness and acknowledge patient advocates…

Nov 8, 2024, 13:00 | Blog

DDF: Curing Stomach Cancer will Host Educational Symposium Highlighting Gastric Cancer Awareness Month

The event will address critical issues, including mental health and treatment side effects. Debbie’s Dream…

Nov 7, 2024, 15:45 | Insight

Four new drugs approved by the FDA in October summarized by Samuel Hume

Samuel Hume, Scientist at the University of Oxford, shared a post on X: “The FDA…

Nov 5, 2024, 14:59 | Blog

FDA Approval for Advanced Gastric Cancer Treatment: A New Option for Patients - The Babak Lab

The Babak Lab posted on LinkedIn: "FDA Approval for Advanced Gastric Cancer Treatment: A New…

Nov 3, 2024, 16:46 | Blog

Lindsey Gasparini: New FDA-approved therapy targets Claudin18.2 in gastric cancers

Lindsey Gasparini, Vice President of Biopharma Data Solutions at NeoGenomics Laboratories, shared a post by…

Oct 26, 2024, 12:41 | Blog

Lucjan Wyrwicz at CSCO on modern and future treatment of gastric cancer

Lucjan Wyrwicz, Head of Department, Dept. of Oncology and Radiotherapy, Maria Skłodowska-Curie Memorial Cancer Center,…

Oct 26, 2024, 10:57 | Blog

Is CRT no longer a component of multidisciplinary care for gastric cancer?

Erman Akkus, Medical Oncology fellow at the Ankara University, Faculty of Medicine, shared a recent…

Oct 23, 2024, 14:20 | Blog

Angelica Petrillo: Recently published key meta-analyses about ICIs in gastric cancer

Angelica Petrillo, Medical Doctor at Ospedale del Mare Napoli, shared a post by Arndt Vogel…

Oct 23, 2024, 14:18 | Insight

Sam Klempner: DKN-01 with Tislelizumab and Chemotherapy in Advanced Gastric or GEJ Adenocarcinoma

Sam Klempner, Associate Professor at Harvard Medical School, shared on X: “Adding to the ever…

Oct 22, 2024, 04:01 | Blog

Erika Ruiz-Garcia: International Symposium on Gastric Cancer

Erika Ruiz-Garcia, Director of Teaching, Instituto Nacional de Cancerología, shared a post on LinkedIn: "Thank you…

Oct 8, 2024, 12:34 | Insight

Regorafenib vs placebo for Refractory Advanced Gastric Cancer, summarised by Erman Akkus

Erman Akkus shared a post on X: "Regorafenib vs placebo for Refractory Advanced Gastric Cancer INTEGRATE…

Oct 8, 2024, 08:47 | Dialogues

ASCO24 Updates: Dr. Patricia Keegan on Neoadjuvant Chemotherapy for Gastric Cancer with Toripalimab

The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…

Oct 7, 2024, 08:15 | Blog

A troubling rise in early-onset cases of Digestive Cancers

Sharing Progress in Cancer Care shared a post on LinkedIn: "Digestive Cancers were once considered…

Oct 4, 2024, 15:10 | Blog

The ESMO Gastric Cancer Living Guideline and Slide Set are updated

The European Society for Medical Oncology shared a post on X: "The ESMO Gastric Cancer…

Oct 2, 2024, 16:08 | Blog

Istvan Petak: What we know about cancer biology and immunology in clinical practice

Istvan Petak shared on Linkedin: ''Hello, Amazing Best-of-ASCO Conference 2024! I was deeply honored to…

Oct 2, 2024, 15:39 | Blog

Tanja Obradovic: FDA ODAC's decision on PD-1 Inhibitors in HER2- Negative Gastric Cancer

Tanja Obradovic shared a post on LinkedIn: "In highly anticipated discussion on September 26th FDA Oncologic Drugs…

Sep 27, 2024, 16:15 | Dialogues

ASCO24 Updates: Dr. Akihito Kawazoe on Regorafenib and Nivolumab for Advanced Gastric Cancer

The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…

Sep 18, 2024, 11:02 | Insight

2024 annual TOGAS EU project consortium in Porto - ECO

European Cancer Organisation shared on LinkedIn: "ECO was in Porto, Portugal for the 2024 annual…

Sep 17, 2024, 16:28 | Blog

Amalya Sargsyan: DestinyGastric03 trial results and HER2+ treatment insights at ESMO24

Amalya Sargsyan posted the following on X: “Great insights from Yelena Janjigian, MD at ESMO24!…

Sep 15, 2024, 10:47 | Societies

No role for pre-operative CRT in the treatment of operable Gastric cancer - ESMO

ESMO shared on LinkedIn: "Final results presented at ESMO24 from the phase III TOPGEAR trial…

Sep 7, 2024, 14:50 | Blog

Medigene Announces U.S. FDA Clearance of IND Application for MDG1015 for Multiple Solid Tumor Indications

Medigene AG, an oncology platform company focused on the research and development of T cell…

Sep 5, 2024, 19:32 | Insight

Francisco Esteva: HER2-targeted therapies are being explored for various other solid tumors

Francisco Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill Hospital,…

Sep 3, 2024, 10:33 | Insight

Nicole Baranda Balmaceda: Fun discussion on CLDN18.2 in gastric cancer

Nicole Baranda Balmaceda shared a post by Tumor Board Tuesday on X, adding: “Join us…

Aug 28, 2024, 14:41 | Insight

Targeting HER2-low gastric cancer, summary by Erman Akkus

Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, shared a recent article…

Aug 28, 2024, 11:11 | Blog

MD Anderson Research Highlights

Featuring a combination treatment for gastric cancer, positive ADC results in colorectal cancer, and a…

Aug 26, 2024, 20:20 | Blog

Tanja Obradovic: Some points of interest from the Relativity-104 study

Tanja Obradovic shared on LinkedIn: "Opdualag, a cocktail of anti Lag-3 (relatlimab) and anti PD1…

Aug 8, 2024, 15:24 | Dialogues

Andrea Eidelman: Curing Stomach Cancer: What Was Debbie's Dream?

Andrea Pola Eidelman, CEO of Debbie's Dream Foundation Curing Stomach Cancer, joins Gevorg Tamamyan on…

Aug 5, 2024, 05:34 | Dialogues

Unlocking the Immune System: Dr. Levisetti on Cue Biopharma's New Biologics

Matteo Levisetti, M.D is chief medical officer of CUE Biopharma which is a clinical-stage biopharmaceutical…

Aug 1, 2024, 07:45 | Blog

May community eradication of Helicobacter pylori prevent gastric cancer?

Erman Akkus, Medical Oncologist at Ankara University, shared on X: "May community eradication of Helicobacter…

Jul 29, 2024, 23:25 | Insight

Akhil Kapoor: Intensifying Chemotherapy in advanced Gastric Cancer doesn't improve survivals

Akhil Kapoor, Associate Professor and Medical Oncology at TMH Varanasi, shared a post on X:…

Jul 28, 2024, 13:46 | Blog

DiCE is involved in several innovative EU-funded research projects to enhance digestive health

Digestive Cancers Europe shared a post on LinkedIn: “Did you know Digestive Cancers Europe (DiCE)…

Jul 20, 2024, 21:29 | Insight

Harry Sokol: The role of Faecali bacterium prausnitzii to boost ICI efficacy in cancer

Sumanta K. Pal shared a post by Harry Sokol, Professor of Gastroenterology at Greater Paris…

Jul 17, 2024, 01:28 | Blog

Florian Lordick: Outstanding 15th APCG 10th SGCC Gastric Cancer Meeting

Florian Lordick, Editor in Chief - ESMO Gastrointestinal Oncology at ESMO, shared a post on…

Jul 15, 2024, 04:26 | Blog

Florian Lordick: 15th APGCC 10th SGCC scientific meeting on Gastric Cancer

Florian Lordick, Director of Education at ESMO, shared on LinkedIn: "Impressions from the 15th APGCC…

Jul 14, 2024, 06:51 | Blog

Angelica Petrillo: The value of PD-L1 in Gastric Cancer

Angelica Petrillo, Medical Doctor at the Medical Oncology Unit at Ospedale del Mare in Naples,…

Jul 10, 2024, 03:31 | Blog

Bilal Alkhaffaf: Healthcare professionals have a responsibility to ensure that resources are used effectively

Bilal Alkhaffaf, Consultant Oesophago-Gastric and Bariatric Surgeon at NHS, shared on LinkedIn: "As healthcare professionals involved…

Jul 7, 2024, 07:08 | Insight

Medigene AG Expands Patent Portfolio with the Patent Grant for NY-ESO-1/LAGE 1a Targeted T Cell Receptor in China

Medigene AG, an immuno-oncology platform company focusing on the discovery and development of T cell…

Jul 4, 2024, 11:21 | Blog

Florian Lordick: New first-line treatment algorithm for advanced gastric cancer published in ESMO

Florian Lordick, Director of Education at ESMO, shared on LinkedIn: "New first-line treatment algorithm for…

Jul 3, 2024, 02:47 | Societies

Seyed Alireza Javadinia: Oesophago-gastric cancer on the third day of ESMOGI24

Seyed Alireza Javadinia, Clinical Oncologist at Sabzevar University of Medical Sciences, shared on LinkedIn: "Oesophago-gastric…

Jun 29, 2024, 13:50 | Drugs

Chemotherapy with adjuvant nivolumab versus placebo for GEJ cancer

Syed A. Ahmad, Chief of Surgical Oncology at The University of Cincinnati, made the following…

Jun 27, 2024, 13:40 | Insight

New study on germline CDH1 variants shows lifetime cancer risks

Yüksel Ürün shared on X: "New study on germline CDH1 variants shows lifetime cancer risks:…

Jun 23, 2024, 14:51 | Blog

Pedro C Barata: Founder mutation CDH1 in Portugal and gastric cancer

Pedro C Barata, GU Med Oncologist at University Hospitals Seidman Cancer Center, posted on X:…

Jun 21, 2024, 07:54 | Insight

New Paper Alert! New Study Reveals Lower than Expected Gastric Cancer Risk for CDH1 Mutation Carriers

New Study Reveals Lower than Expected Gastric Cancer Risk for CDH1 Mutation Carriers Authors: Carrie…

Jun 17, 2024, 12:11 | Cancer Types

Stomach Cancer: Symptoms and Causes, Types, Diagnosis and Treatment

Stomach cancer, commonly referred to as gastric cancer, is a malignant condition originating from the…

Jun 8, 2024, 08:22 | Blog

Michel Ducreux and Teresa Macarulla discussing GI Cancer research on ESMO Daily Reporter

ESMO shared on LinkedIn: "Whilst neoadjuvant chemotherapy is now a well-established strategy for treating some…

May 26, 2024, 16:38 | Blog

Zouina Sarfraz: Two of my abstracts have been published for the 2024 ASCO Annual Meeting

Zouina Sarfraz, Associate Editor at BMC, shared a post on LinkedIn: "I am pleased to announce…

May 19, 2024, 05:52 | Insight

Ahmed Abdelhakeem: Our meta-analysis on survival in stage IV gastric cancer patients with ovarian metastases

Ahmed Abdelhakeem, Chief Resident at Baptist Hospitals of Southeast Texas, shared on X: "New Publication…

May 16, 2024, 16:51 | Insight

10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily

In the fast-growing field of oncology, we are witnessing significant advances in several treatment modalities…

May 10, 2024, 17:49 | Drugs

Piotr Wysocki: Relatlimab does not improve the activity of nivolumab plus chemotherapy

Piotr Wysocki recently posted on LinkedIn: "RELATIVITY-060 was an open-label phase II study investigating the…

May 2, 2024, 15:20 | Blog

Paolo Tarantino: Impressive to think at the journey of ADCs over the last five years

Paolo Tarantino shared on LinkedIn: "Impressive to think at the journey of ADCs over the last…

Apr 30, 2024, 07:31 | Insight

Top 5 posts of the week by Cancer Network

Cancer Network shared on their X/Twitter page: "View our top 5 posts of the week:…

Apr 22, 2024, 11:11 | Insight

New Paper Alert! Impact of Pathological Complete Response on Long-Term Survival in Locally Advanced Gastric Cancer Patients Treated with Neoadjuvant Chemotherapy

Impact of Pathological Complete Response on Long-Term Survival in Locally Advanced Gastric Cancer Patients Treated…

Apr 20, 2024, 08:16 | Blog

Tanja Obradovic: One exciting novel approach is just about to enter clinical development

Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON plc, shared a post on LinkedIn: "Cell…

Apr 16, 2024, 01:34 | Insight

Arndt Vogel: Prognostic and predictive impact of sex in locally advanced Microsatellite instability (MSI) gastric or gastroesophageal junction cancer

Arndt Vogel, Managing Senior Consultant and Professor in the Department of Gastroenterology, Hepatology and Endocrinology…

Apr 15, 2024, 16:32 | Blog

Yelena Janjigian at the Oncology Congress!

Yelena Janjigian shared a post on X: “Our mission Memorial Sloan Kettering Cancer Center is…

Apr 15, 2024, 13:00 | Insight

Sumanta K. Pal: Nice paper from Yanghee Woo's group

Sumanta K. Pal, Co-director of City of Hope's Kidney Cancer Program, shared a post on…

Apr 11, 2024, 16:08 | Insight

New Paper Alert! Exploring the Genomic Diversity of Cancer in Latin American Populations

Exploring the Genomic Diversity of Cancer in Latin American Populations Authors: Alejandro Ruíz-Patiño, Leonardo Rojas,…

Apr 11, 2024, 14:45 | Insight

Wafik El-Deiry: Susan Galbraith speaks about AstraZeneca oncology portfolio and collaboration opportunities at the AACR Oncology Industry Partnering Event in San Diego

Wafik El-Deiry, Director of the Legorreta Cancer Center at Brown University, recently posted on LinkedIn:…

Apr 3, 2024, 15:36 | Blog

Adam Yopp: Sam C. Wang, the epitome of a surgeon-scientist, recently awarded second NIH R01 grant studying gastric cancer

Adam Yopp, Liver Surgeon at UT Southwestern Medical Center, shared a post on X/Twitter: "Sam…

Mar 26, 2024, 15:10 | Blog

Yelena Janjigian: We are meeting and reviewing the candidates now for Debbies Dream Foundation Gastric Cancer Investigator Fellowship

Yelena Janjigian shared a post by Debbie's Dream Foundation on X, adding: "We are meeting and reviewing…